Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03129661

Ligand	Ligand name	Chain	PDB	Tanimoto
GB7	(3R,4R,5R)-3,4-dihydroxy-5-({[(1R)-2-hydroxy-1-phenylethyl]amino}methyl)-1-methylpyrrolidin-2-one	A	3DDG	0.73
78A	N-({(2S,3S)-3-[(BENZYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINE	A	2DCD	0.71
ARQ	BENZOYLAMINO-BENZYL-METHYL-[2-HYDROXY-3-[1-METHYL-ETHYL-OXY-N-FORMAMIDYL]-4-PHENYL-BUTYL]-AMMONIUM	A	3AID	0.72
B1L	3-[(4-HYDROXYBENZOYL)AMINO]AZEPAN-4-YL 4-HYDROXYBENZOATE	A	1REJ	0.71
KAF	N-{(5S)-4,4-dihydroxy-6-phenyl-5-[(phenylcarbonyl)amino]hexanoyl}-L-phenylalanine	A	3BKK	0.71
KHA	1-(4-{[(2-HYDROXYETHYL)AMINO]CARBONYL}BENZYL)-1-METHYLPIPERIDINIUM	H,L,X,Y	1UWG	0.72
HBZ	N-{[(4-hydroxyphenyl)carbonyl]carbamoyl}-beta-D-glucopyranosylamine	A	2QN7	0.73
NBX	N-{[(4-aminophenyl)carbonyl]carbamoyl}-beta-D-glucopyranosylamine	A	2QN9	0.77
PH5	2-PHENYL-PROP5AC	A,B	2BVE	0.76
MNI	N-{[(2R,3R,4R,5R)-3,4-DIHYDROXY-5-(HYDROXYMETHYL)PYRROLIDIN-2-YL]METHYL}-4-(DIMETHYLAMINO)BENZAMIDE	A,B	2OYM	0.78
S13	(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol	A	2QRQ	0.71
EJT	1,3-DI(N-PROPYLOXY-A-MANNOPYRANOSYL)-CARBOMYL 5-METHYAZIDO-BENZENE	A,B	1QGL	0.82
F59	N-[(biphenyl-4-ylcarbonyl)carbamoyl]-beta-D-glucopyranosylamine	A	2QLN	0.78
DBZ	3-(BENZOYLAMINO)-L-ALANINE	A,B,C,D	1SN9	0.71
DBZ	3-(BENZOYLAMINO)-L-ALANINE	A,B	1SNE	0.71
DBZ	3-(BENZOYLAMINO)-L-ALANINE	A,B,C,D	1SNA	0.71
DBZ	3-(BENZOYLAMINO)-L-ALANINE	A,B	1XOF	0.71
BFN	5-(acetylamino)-2,6-anhydro-3,5,9-trideoxy-3-fluoro-9-[(phenylcarbonyl)amino]-D-arabino-L-galacto-nononic acid	A	3B69	0.84
SK3	(1R,2R,3S,4S,5R)-5-(BENZYLAMINO)CYCLOPENTANE-1,2,3,4-TETROL	A	2F7R	0.75
YC2	N-{[(1S)-1-carboxy-5-{[(4-iodophenyl)carbonyl]amino}pentyl]carbamoyl}-L-glutamic acid	A	3D7H	0.71
GB6	(3R,4R,5R)-3,4-dihydroxy-5-({[(1R)-2-hydroxy-1-phenylethyl]amino}methyl)pyrrolidin-2-one	A	3DDF	0.73
HOP	(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL	H,L	1D6V	0.71
HOP	(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL	A,B,H,L	1AXS	0.71
SUW	ME-A-9-N-(NAPHTHYL-2-CARBONYL)-AMINO-9-DEOXY-NEU5AC	A	1OD7	0.81
SC7	N'-{(1S,2R)-1-(3,5-DIFLUOROBENZYL)-2-[(2R,4S)-4-ETHOXYPIPERIDIN-2-YL]-2-HYDROXYETHYL}-5-METHYL-N,N-DIPROPYLISOPHTHALAMIDE	A,B	2QP8	0.75
F55	N-{[(4-chlorophenyl)carbonyl]carbamoyl}-beta-D-glucopyranosylamine	A	2QN3	0.77
LHA	DOUBLY FUNCTIONALIZED PAROMOMYCIN PM-II-162	A,B	2PWT	0.79
EG2	AMINODI(ETHYLOXY)ETHYLAMINOCARBONYLBENZENESULFONAMIDE	A	1CNX	0.7
NBY	N-{[(4-nitrophenyl)carbonyl]carbamoyl}-beta-D-glucopyranosylamine	A	2QN8	0.73
AI1	N-BENZYL-3-(ALPHA-D-GALACTOS-1-YL)-BENZAMIDE	D,E,F,G,H,L,M,N,O,P	1FD7	0.74
F68	N-{[(4-methylphenyl)carbonyl]carbamoyl}-beta-D-glucopyranosylamine	A	2QLM	0.82
BND	ME-A-N-BENZOYL-AMINO-9-DEOXY-NEU5AC	A	1OD9	0.87
BZD		A	1K06	0.82
BZD		A	1K08	0.82
BZD		A	2QNB	0.82
CS7	N'-[(1S,2R)-2-[(2R,4R)-4-(BENZYLOXY)PYRROLIDIN-2-YL]-1-(3,5-DIFLUOROBENZYL)-2-HYDROXYETHYL]-5-METHYL-N,N-DIPROPYLISOPHTHALAMIDE	A,B	2QMD	0.73
C90	N-{(1S,2R)-2-hydroxy-1-[(hydroxyamino)carbonyl]propyl}-4-{[4-(morpholin-4-ylmethyl)phenyl]ethynyl}benzamide	A	2JT2	0.72
BDU	ME-A-9-N-(BIPHENYL-4-CARBONYL)-AMINO-9-DEOXY-NEU5AC	A	1ODA	0.84
S2D	N-BENZOYL-D-ALANINE	A,B	2JCI	0.74
2SK	(1R,2R,3R,4S,5R)-4-(BENZYLAMINO)-5-(METHYLTHIO)CYCLOPENTANE-1,2,3-TRIOL	A	2F7P	0.71
OTG	ORTHO-TOLUOYLGLUCOSAMINE	A	2YHX	0.94